OA09337A - "Agents bloquants de l'effet ou de la formation du facteur EDRF pour le traitement des chocs". - Google Patents

"Agents bloquants de l'effet ou de la formation du facteur EDRF pour le traitement des chocs".

Info

Publication number
OA09337A
OA09337A OA59932A OA59932A OA09337A OA 09337 A OA09337 A OA 09337A OA 59932 A OA59932 A OA 59932A OA 59932 A OA59932 A OA 59932A OA 09337 A OA09337 A OA 09337A
Authority
OA
OAPI
Prior art keywords
edrf
shock
formation
treatment
effect
Prior art date
Application number
OA59932A
Other languages
English (en)
French (fr)
Inventor
Braquet Pierre
Chabrier Delass Pierre-Etienne
Guillon Jean-Michel
Auguet Michel
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of OA09337A publication Critical patent/OA09337A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA59932A 1989-12-22 1990-12-21 "Agents bloquants de l'effet ou de la formation du facteur EDRF pour le traitement des chocs". OA09337A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929076A GB8929076D0 (en) 1989-12-22 1989-12-22 Treatment of shock by blocking agents of edrf effect or formation

Publications (1)

Publication Number Publication Date
OA09337A true OA09337A (fr) 1992-09-15

Family

ID=10668428

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59932A OA09337A (fr) 1989-12-22 1990-12-21 "Agents bloquants de l'effet ou de la formation du facteur EDRF pour le traitement des chocs".

Country Status (21)

Country Link
US (1) US5081148A (enEXAMPLES)
JP (1) JP2706578B2 (enEXAMPLES)
KR (1) KR950005866B1 (enEXAMPLES)
AT (1) AT403122B (enEXAMPLES)
AU (1) AU629777B2 (enEXAMPLES)
BE (1) BE1005531A5 (enEXAMPLES)
CA (1) CA2032904C (enEXAMPLES)
CH (1) CH681692A5 (enEXAMPLES)
DE (1) DE4041283C2 (enEXAMPLES)
DK (1) DK176168B1 (enEXAMPLES)
FR (1) FR2656220B1 (enEXAMPLES)
GB (2) GB8929076D0 (enEXAMPLES)
HK (1) HK134693A (enEXAMPLES)
IE (1) IE64403B1 (enEXAMPLES)
IT (1) IT1246511B (enEXAMPLES)
LU (1) LU87867A1 (enEXAMPLES)
MY (1) MY105328A (enEXAMPLES)
NL (1) NL194717C (enEXAMPLES)
OA (1) OA09337A (enEXAMPLES)
SE (1) SE504922C2 (enEXAMPLES)
ZA (1) ZA9010004B (enEXAMPLES)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
ES2181726T3 (es) * 1993-10-21 2003-03-01 Searle & Co Amidinoderivados utiles como inhibidores de oxido nitrico sintasa.
ATE177078T1 (de) * 1993-10-21 1999-03-15 Searle & Co Amidino-derivate als no-synthetase inhibitoren
GB9404400D0 (en) * 1994-03-07 1994-04-20 Wood Pauline J Potentiation of bioreductive agents
DE69518631T2 (de) * 1994-03-10 2001-01-11 G.D. Searle & Co., Chicago L-n6-(1-iminoethyl)lysin - derivate und ihre verwendung als no-synthase - inhibitoren
US5684008A (en) * 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
FR2727111B1 (fr) * 1994-11-21 1997-01-17 Hoechst Lab Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
CA2206119C (en) * 1994-12-12 2008-05-13 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
FR2730930B1 (fr) 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
CN1105706C (zh) * 1995-04-20 2003-04-16 G·D·瑟尔公司 用作氧化氮合成酶抑制剂的环状脒基制剂
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
BR9509985A (pt) * 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US6620848B2 (en) 1997-01-13 2003-09-16 Smithkline Beecham Corporation Nitric oxide synthase inhibitors
US6369272B1 (en) 1997-01-13 2002-04-09 Glaxosmithkline Nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
GB9811599D0 (en) 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors
JP2002517502A (ja) 1998-06-10 2002-06-18 ジー・ディー・サール・アンド・カンパニー 複素二環状及び三環状一酸化窒素シンターゼ阻害剤
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
WO2005063752A1 (en) 2003-12-30 2005-07-14 Vasopharm Biotech Gmbh 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931921A (en) * 1960-12-22 1963-07-24 Lab Roques Therapeutic compositions intended for the treatment of any hepatic malfunctionings
DE1767212B1 (de) * 1967-04-13 1971-05-06 Sumitomo Chemical Co Verfahren zur Herstellung injizierbarer Arzneimittel
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
FR2320759A1 (fr) * 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
IT1127321B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi
IT1127322B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
JPS57197211A (en) * 1981-05-28 1982-12-03 Sumitomo Chem Co Ltd Useful eye drop composition
JPS57200361A (en) * 1981-06-03 1982-12-08 Sumitomo Chem Co Ltd "indomethacin(r)" pharmaceutical with low irritant action
JPS6239524A (ja) * 1985-08-13 1987-02-20 Toko Yakuhin Kogyo Kk 消炎鎮痛軟膏剤
JPH0236570B2 (ja) * 1985-05-30 1990-08-17 Toko Yakuhin Kogyo Kk Shoenchintsunankozai
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.

Also Published As

Publication number Publication date
BE1005531A5 (fr) 1993-09-28
JP2706578B2 (ja) 1998-01-28
DK304190D0 (da) 1990-12-21
IT9022413A1 (it) 1991-06-23
GB2240041B (en) 1993-09-01
IE904592A1 (en) 1991-07-03
KR910011253A (ko) 1991-08-07
DE4041283A1 (de) 1991-06-27
FR2656220B1 (fr) 1995-01-13
FR2656220A1 (fr) 1991-06-28
DE4041283C2 (de) 2000-07-13
ZA9010004B (en) 1991-10-30
LU87867A1 (fr) 1991-05-07
NL194717C (nl) 2003-01-07
KR950005866B1 (ko) 1995-06-02
AU6837690A (en) 1991-06-27
AT403122B (de) 1997-11-25
GB9028013D0 (en) 1991-02-13
CA2032904C (en) 1996-01-02
CH681692A5 (enEXAMPLES) 1993-05-14
IT9022413A0 (it) 1990-12-18
GB2240041A (en) 1991-07-24
SE9003974D0 (sv) 1990-12-12
NL9002720A (nl) 1991-07-16
ATA260690A (de) 1997-04-15
AU629777B2 (en) 1992-10-08
MY105328A (en) 1994-09-30
SE504922C2 (sv) 1997-05-26
US5081148A (en) 1992-01-14
SE9003974L (sv) 1991-06-23
IE64403B1 (en) 1995-08-09
GB8929076D0 (en) 1990-02-28
HK134693A (en) 1993-12-17
CA2032904A1 (en) 1991-06-23
DK304190A (da) 1991-06-23
NL194717B (nl) 2002-09-02
JPH04364124A (ja) 1992-12-16
DK176168B1 (da) 2006-11-13
IT1246511B (it) 1994-11-19

Similar Documents

Publication Publication Date Title
OA09337A (fr) "Agents bloquants de l'effet ou de la formation du facteur EDRF pour le traitement des chocs".
FR2685206B1 (fr) Dispositif de drainage implantable pour le traitement de l'hydrocephalie.
FR2567758B1 (fr) Compositions therapeutiques a base de ginkgolides pour le traitement ou la prevention des maladies provoquees par l'acether du facteur d'activation des plaquettes (paf-acether)
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
MA22180A1 (fr) Composition fongicide pour le traitement de semences
FR2663044B1 (fr) Appareil pour le traitement de surfaces.
MA25404A1 (fr) Methode pour le traitement des desordres neurologiques ou neuropsychiatriques.
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
FR2694384B1 (fr) Traitement de la surface de réfractaires.
DZ2012A1 (fr) Benzamides pour le traitement de dégénérescences neurologiques.
FR2615845B1 (fr) Doseuse pour le traitement de boissons en bouteilles
ZA931063B (en) Treatment of glaucoma.
EP0667157A4 (en) AGENT FOR TREATING CYCLING COMPLAINTS.
FR2680123B1 (fr) Procede de traitement de residus fortement polluants pour l'environnement.
FR2683722B1 (fr) Medicament pour le traitement de fond de l'asthme a base de beta-carotene.
FR2606600B1 (fr) Machine pour le nettoyage des poireaux
FR2666228B1 (fr) Composition pour le traitement des surcharges ponderales et/ou de la cellulite.
FR2663648B1 (fr) Dispositif electroacoustique de traitement de l'eau.
FR2705574B1 (fr) Valve de drainage implantable pour le traitement de l'hydrocéphalie.
FR2657005B1 (fr) Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes.
FR2668030B3 (fr) Appareil pour le traitement de la vigne notamment a l'encontre du botrytis.
MA21630A1 (fr) Compositions pour le traitement de leishmanioses .
FR2686246B3 (fr) Orthese de poignet pour le traitement de l'epicondylalgie.
RO83870A2 (ro) Preparat fitoterapeutic pentru tratamentul alveolitei poste0tractionale
ES1009533Y (es) Deposito dosificador para la acogida y cesion de agentes de tratamiento para la colada.